Spots Global Cancer Trial Database for high grade serous
Every month we try and update this database with for high grade serous cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
BEACON - ABC in Recurrent Platinum Resistant HGSOC | NCT03363867 | Ovarian Cancer Fallopian Tube ... Primary Periton... | Atezolizumab Bevacizumab Cobimetinib | 18 Years - | Peter MacCallum Cancer Centre, Australia | |
Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer | NCT06404671 | Ovarian Epithel... | Delayed interva... Early interval ... | 18 Years - 75 Years | Alexandria University | |
BEACON - ABC in Recurrent Platinum Resistant HGSOC | NCT03363867 | Ovarian Cancer Fallopian Tube ... Primary Periton... | Atezolizumab Bevacizumab Cobimetinib | 18 Years - | Peter MacCallum Cancer Centre, Australia | |
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | NCT02855944 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | Chemotherapy Rucaparib | 18 Years - | pharmaand GmbH | |
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | NCT02855944 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | Chemotherapy Rucaparib | 18 Years - | pharmaand GmbH | |
A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT05613088 | Neoplasms, Ovar... | MORAb-202 Paclitaxel Pegylated Lipos... Topotecan | 18 Years - | Bristol-Myers Squibb |